Masayuki Kohno

A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells

Megumi Kawamoto, Tomohisa Horibe, Masayuki Kohno et al. · BMC Cancer · 2011 · 78 citations · Full text

Combination of hybrid peptide with biodegradable gelatin hydrogel for controlled release and enhancement of anti-tumor activity in vivo

Arong Gaowa, Tomohisa Horibe, Masayuki Kohno et al. · Journal of Controlled Release · 2014 · 74 citations

Biopolymer Gel, Cell-based Drug Delivery, Biodegradable Gelatin Hydrogel +4

Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen

Masayuki Kohno, Sho Yamasaki, Victor L. J. Tybulewicz et al. · Blood · 2004 · 71 citations · Full text

A novel hybrid peptide targeting EGFR-expressing cancers

Masayuki Kohno, Tomohisa Horibe, Mari Haramoto et al. · European Journal of Cancer · 2010 · 67 citations

Peptide Library, Egfr-expressing Cancers, Peptide Therapeutic +6

Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent

Tomohisa Horibe, Masayuki Kohno, Mari Haramoto et al. · Journal of Translational Medicine · 2011 · 66 citations · Full text